· Published by Health Canada · Official notice
| Brand | Product Name | Market Authorization | Dosage Form | Strength | Lot |
|---|---|---|---|---|---|
| Apo | Apo-Amitriptyline | DIN 02403137 | Tablet | Amitriptyline Hydrochloride 10 mg | RN6384, RR0265, RR0266, RV1644, RV1645, RW8597, RW8598, TA6008, TA6009, TF8585, TF8586, TF8587, TF8588, TF8589, TW2842, TW2843 |
| Apo | Apo-Amitriptyline | DIN 02403145 | Tablet | Amitriptyline Hydrochloride 25 mg | RM0519, RM8130, RR0780, RR0781, RV1656, RV1657, RW8691, TA6061, TA6062, TF8602, TF8603 |
Affected lots exceed or may exceed the interim acceptable intake limit for N-nitroso-nortriptyline (NNORT)